News

Florida Institute Commercialization of Florida Technology

Apr 11th 2023

Florida Institute and MPWRM Resource Center Fund Amend Surgical

Alachua-based Company Accelerates Development and Market Launch of Amend Tissue Tape™ Amend Surgical, Inc., an Alachua-based medical device company, announced today that it has finalized a funding agreement with the Institute for Commercialization of Florida Technology (the Florida Institute) along with being awarded a substantial… Read More

Florida Institute Commercialization of Florida Technology

May 4th 2022

Amend Surgical Receives Funding For Tissure

Amend Surgical Receives Funding for Suture-less Nerve Repair Device Amend Surgical, Inc., an Alachua-based medical device company, announced today that it has been awarded a substantial product development funding from The Michigan-Pittsburgh-Wyss Regenerative Medicine (MPWRM) Resource Center to commercialize a novel, suture-less solution for the… Read More

Wyss Institute

Jul 21st 2020

Amend Surgical To Develop Wound-Closure Method Alternative Using Tough Gel Technology

Wyss Institute Licenses Tough Gel Technology To Amend Surgical The Wyss Institute has developed a surgical adhesive that can adhere to wet and dynamic surfaces inside the body, including the heart, lung, tendons, cartilage, and bone. Coupled with a novel tough hydrogel, this surgical adhesive… Read More

Florida Institute

May 24th 2017

Florida Institute Funds Alachua-based Amend Surgical

New Funding Agreement Will Allow Research Expansion Alachua-Based Medical Device Company Looks to Grow Reach of Biomimetic Bone GAINESVILLE, Fla. and BOCA RATON, Fla., May 18, 2017 /PRNewswire-USNewswire/ —The Florida Institute for… Read More

UF Office of Research | University of Florida

Apr 6th 2017

Amend Surgical Signs Agreement With UFRF for Biomimetic Bone

Amend Announces Exclusive Agreement With UFRF For Biomimetic Bone Patents Artificial Bone Substitute Closely Mimics Composition & Structure of Natural Bone ALACHUA, Fla. — (BUSINESS WIRE) — Amend Surgical, Inc. (Amend), a medical device company focused on enhancing the regenerative capacity of bone replacement products, announced today… Read More

NanoFUSE Bioactive Matrix

Mar 2nd 2017

Amend Surgical Announces 510(K) Clearance for NanoFUSE® BA

Amend Surgical Announces 501(K) Clearance for NanoFUSE® BA Alachua Specialty Medical Device Company to Market Product as Bone Graft Extender ALACHUA, Fla. — (BUSINESS WIRE) — Amend Surgical, Inc., a medical device company focused on enhancing the regenerative capacity of bone replacement products, announced today that… Read More

Amend Surgical

Apr 15th 2016

Amend Surgical Granted Rights to NanoFUSE

Nanotherapeutics Grants Worldwide Rights to Amend Surgical, Inc. for NanoFUSE® DBM Unique Bone Void Filler Will be the Anchor Product in Amend’s Product Portfolio ALACHUA, Fla. — (BUSINESS WIRE) — Nanotherapeutics, Inc., an integrated biopharmaceutical company with a focus on advanced development and… Read More

CALL US